72 / 100

Dr. Joonsu Han | Immunoengineering | Young Scientist Award

Postdoctoral Appointee, Argonne National Laboratory, United States

Joonsu Han is a skilled researcher specializing in biomaterials and cancer immunotherapy. He is currently a Postdoctoral Appointee at Argonne National Laboratory, Illinois, focusing on cutting-edge research in bioengineering and immuno-oncology. His academic journey started with a Bachelor’s degree in Materials Science and Engineering with Highest Honors from Georgia Institute of Technology, followed by a Ph.D. candidate position at the University of Illinois, Urbana-Champaign. Joonsu’s work spans advanced biomaterials, immunotherapy, and metabolic engineering to enhance dendritic cell vaccines, making significant contributions to cancer treatment.

Publication Profile

Google Scholar

Education

Joonsu Han holds a B.S. in Materials Science and Engineering with Highest Honors from the Georgia Institute of Technology (2017). He is currently a Ph.D. candidate at the University of Illinois, Urbana-Champaign, where he is set to complete his doctoral studies in 2024. Additionally, Joonsu is a Cancer Scholars for Translational and Applied Research (C☆STAR) Trainee at the Cancer Center at Illinois, further enhancing his expertise in cancer research.
📚👨‍🎓

Experience

Joonsu’s experience spans across several prestigious institutions, including his current role as a Postdoctoral Appointee at Argonne National Laboratory. He also completed a C☆STAR program Trainee position at the Cancer Center at Illinois. During his Ph.D. research, Joonsu contributed to a wide range of innovative cancer immunotherapy projects, including enhancing dendritic cell functionality for vaccine development and creating bio-adhesive hydrogels for in situ immune cell recruitment. His previous research experience at Georgia Tech focused on cardiac regenerative materials.
🧪💼

Awards and Honors

Joonsu has received several awards throughout his academic journey, including the Fall 2022 Conference Presentation Award from the Graduate College at UIUC and the prestigious C STAR Award from the Cancer Center at Illinois. He has also been recognized for his conference presentations and his innovative work in cancer immunotherapy and biomaterials.
🏆✨

Research Focus

Joonsu Han’s research focuses on cancer immunotherapy and the development of novel biomaterials to enhance the efficacy of cancer treatments. His work with dendritic cell vaccines, self-adjuvanting mRNA vaccines, and advanced bio-adhesive hydrogels aims to improve tumor-targeted therapies and immune cell modulation. Joonsu is particularly interested in utilizing metabolic glycoengineering and other biotechnological approaches to optimize dendritic cell functionality for improved antitumor efficacy.
🔬🧬

Conclusion

Joonsu Han is a promising researcher whose work in cancer immunotherapy and biomaterial design is paving the way for innovative treatments. His expertise in advanced materials, cell-based assays, and immunoengineering continues to have a significant impact on the field. With numerous peer-reviewed publications and awards, Joonsu’s contributions to medical research are poised to benefit cancer patients worldwide.
💡🌍